Abstract: An abrasive article may include an organic bond material, abrasive particles contained within the organic bond material and a plasticizer contained within the organic bond material. The plasticizer may include at least one of an aromatic phenyl group, a heteroaromatic furyl group, or a saturated aliphatic hydrocarbon. The plasticizer may further include a polar group.

Abstract: A curable composition includes a hydrogen-bonded prepolymer, a plasticizer, and, optionally, a crosslinking agent. The plasticizer includes a reactive plasticizer having structure (I), (II), or (III), wherein X is —OR1, —N(R1)2, —R4—OR1, or —R4—N(R1)2, wherein R1 is independently at each occurrence hydrogen or C1-6 alkyl, and R4 is C1-12 alkylene; y is zero or 1; z is zero or 1; R2 is C1-12 alkyl; and R3 is C1-12 alkyl when z is 1, or R3 is C1-12 alkyl or H when z is zero.

Abstract: A curable composition includes a hydrogen-bonded prepolymer, a plasticizer that includes an alkyl benzoate or an alkyl phenyl ketone, and, optionally, a crosslinking agent. The plasticizer promotes a high extent of crosslinking and provides a more positive health and safety profile than the incumbent plasticizer, furfural. A cured resin and a method of forming it are described.

Abstract: A curable composition includes a hydrogen-bonded prepolymer, a plasticizer that includes an alkyl benzoate or an alkyl phenyl ketone, and, optionally, a crosslinking agent. The plasticizer promotes a high extent of crosslinking and provides a more positive health and safety profile than the incumbent plasticizer, furfural. A cured resin and a method of forming it are described.

Abstract: A curable composition includes a hydrogen-bonded prepolymer, a plasticizer, and, optionally, a crosslinking agent. The plasticizer includes a reactive plasticizer having structure (I), (II), or (III), wherein X is —OR1, —N(R1)2, —R4—OR1, or —R4—N(R1)2, wherein R1 is independently at each occurrence hydrogen or C1-6 alkyl, and R4 is C1-12 alkylene; y is zero or 1; z is zero or 1; R2 is C1-12 alkyl; and R3 is C1-12 alkyl when z is 1, or R3 is C1-12 alkyl or H when z is zero.

Abstract: An abrasive article may include an organic bond material, abrasive particles contained within the organic bond material and a plasticizer contained within the organic bond material. The plasticizer may include at least one of an aromatic phenyl group, a heteroaromatic furyl group, or a saturated aliphatic hydrocarbon. The plasticizer may further include a polar group.

Abstract: A polyester or polyester copolymer based composition, such as a polylactic acid based composition, is provided herein. The polyester or polyester copolymer based composition may include a plasticizer, such as an ether based, an ester based, and/or an ether-ester based plasticizer.

Abstract: A composition includes a blend of (a) a multi-block copolymer including at least one block of an elastomeric polymer and at least one block of a first polymer including a chiral polymer having a stereo isomeric configuration; and (b) a second polymer including an anti-chiral polymer corresponding to the chiral polymer in (a), wherein the second polymer includes an opposite handed stereo isomeric configuration to the chiral polymer in (a); wherein the blend of the chiral polymer and the anti-chiral polymer form stereo complex sites. A flexible tubing material further includes the blend. In an embodiment, a method of making the blend material is also provided.

Abstract: A polyester or polyester copolymer based composition, such as a polylactic acid based composition, is provided herein. The polyester or polyester copolymer based composition may include a plasticizer, such as an ether based, an ester based, and/or an ether-ester based plasticizer.

Abstract: Methods for modulating the release rate of a drug coated stent are disclosed.

Abstract: The present invention provides an implantable medical device coating that has improved stability, a medical device coated with such coating, and a method of increasing the stability of an implantable medical device coating, wherein the coating comprises a stereocomplex f poly(D-lactic acid) and poly(L-lactice acid).

Abstract: A composition includes a) a melt processable polymer including at least one chemical moiety having a partial charge; and b) a nucleating agent having a surface charge that is opposite the partial charge of the chemical moiety of the polymer, wherein the nucleating agent accelerates the rate of crystallization of the melt processable polymer; wherein the nucleating agent has a melting point greater than the melting point of the melt processable polymer. In an embodiment, a method of making the composition is also provided.

Abstract: Methods for modulating the release rate of a drug coated stent are disclosed.

Abstract: A composition includes a blend of (a) a multi-block copolymer including at least one block of an elastomeric polymer and at least one block of a first polymer including a chiral polymer having a stereo isomeric configuration; and (b) a second polymer including an anti-chiral polymer corresponding to the chiral polymer in (a), wherein the second polymer includes an opposite handed stereo isomeric configuration to the chiral polymer in (a); wherein the blend of the chiral polymer and the anti-chiral polymer form stereo complex sites. A flexible tubing material further includes the blend. In an embodiment, a method of making the blend material is also provided.

Abstract: Methods for modulating the release rate of a drug coated stent are disclosed.

Abstract: Implantable medical device coatings that have improved mechanical stability and medical devices coated with such coatings are disclosed.